Unaudited Pro Forma Condensed Combined Balance Sheet. The following adjustments were made in the preparation of the Unaudited Pro Forma Condensed Combined Balance Sheet as of June 30, 2022:
Unaudited Pro Forma Condensed Combined Balance Sheet. As of January 23, 2015 (in millions) Historical Medtronic Historical Covidien(1) Reclassification Adjustments Footnote Reference Acquisition Adjustments Footnote Reference Financing Adjustments Footnote Reference Pro Forma ASSETS Current assets: Cash and cash equivalents $ 17,231 $ 1,818 $ — $ (16,080 ) 5(a), 5(c) $ 3,000 5(m) $ 5,806 — (53 ) 5(o) — (110 ) 5(i) Investments 13,917 — — — — 13,917 Accounts receivable, net 3,568 1,451 — — — 5,019 Inventories 1,875 1,422 — 858 5(q) — 4,155 Prepaid expenses and other current assets 1,570 896 13 7(a) — — 2,479 Total current assets 38,161 5,587 13 (15,385 ) 3,000 31,376 Property, plant, and equipment, net 2,326 1,984 — 766 5(f) — 5,076 Goodwill 10,950 8,823 — 21,928 5(h) — 41,701 Other intangible assets, net 2,339 3,209 — 22,551 5(e) — 28,099 Other assets 1,457 1,012 — (23 ) 5(k) (4 ) 5(l) 2,572 130 5(g) — Total assets $ 55,233 $ 20,615 $ 13 $ 29,967 $ 2,996 $ 108,824 LIABILITIES, REDEEMABLE NON-CONTROLLING INTEREST, AND SHAREHOLDERS’ EQUITY Current liabilities: Short-term borrowings $ 2,185 $ 1,010 $ — $ — $ — $ 3,195 Accrued expenses 3,428 1,905 13 7(a) 97 5(n) — 5,653 — 210 5(g) — Total current liabilities 5,613 2,915 13 307 — 8,848 Long-term debt 26,641 4,051 — 421 5(p) 3,000 5(m) 34,113 Other long-term liabilities 2,806 3,215 — 5,713 5(g) — 11,734 Total liabilities 35,060 10,181 13 6,441 3,000 54,695 Commitments and contingencies Redeemable noncontrolling interest — 62 — — — 62 Shareholders’ equity: Ordinary shares — 91 — (91 ) 5(j) — — Ordinary shares held in treasury at cost — (164 ) — 164 5(j) — — Retained earnings 20,735 10,414 — (10,414 ) 5(j) (4 ) 5(l) 54,728 — (97 ) 5(n) — — (53 ) 5(o) — — 33,435 5(b) — Total shareholders’ equity 20,173 10,372 — 23,526 (4 ) 54,067 Total liabilities, redeemable noncontrolling interest and shareholders’ equity $ 55,233 $ 20,615 $ 13 $ 29,967 $ 2,996 $ 108,824 (1) As of December 26, 2014 Unaudited Pro Forma Condensed Combined Statement of Earnings For the Nine Months Ended January 23, 2015 (In millions except per share data) Historical Medtronic Historical Covidien (Note 4) Reclassification Adjustments Footnote Reference Acquisition Adjustments Footnote Reference Financing Adjustments Footnote Reference Pro Forma Net sales $ 12,957 $ 8,108 $ — $ — $ — $ 21,065 Cost of products sold 3,375 3,218 (126 ) 7(c) 22 6(e) — 6,327 (4 ) 7(d) — — 7 7(e) — — (126 ) 7(f) — — (39 ) 7(h) — — Selling, general, and administrative expense 4,909 2,870 (48 ) 7(b) 1,301 6(d) — 8,892 126 7(c) 1...
Unaudited Pro Forma Condensed Combined Balance Sheet. The unaudited pro forma condensed combined balance sheet give effect to the following pro forma adjustments:
Unaudited Pro Forma Condensed Combined Balance Sheet. China VTV Limited, a Nevada Corporation China VTV Limited, a Hong Kong Company February 28, 2019 February 28, 2019 Pro FormaAdjustment Note CombinedPro Forma ASSETS Current Assets Cash and cash equivalents $ 17,548 $ - $ 17,548 Total Current Assets 17,548 - - 17,548 Total Assets $ 17,548 $ - $ - $ 17,548 LIABILITIES AND STOCKHOLDERS’ DEFICIT Current Liabilities Accrued expenses $ 23,163 $ - $ - $ 23,163 Due to related parties 456,474 136,265 - 592,739 Total Current Liabilities 479,637 136,265 - 615,902 Total Liabilities 479,637 136,265 - 615,902 Stockholders’ deficit Common Stock 105,000 128,982 (18,432 ) (1) 215,550 Additional paid-in capital 10,663 2,072,683 18,432 (1) 1,524,026 (577,752 ) (2) Accumulated deficit (577,752 ) (2,337,167 ) 577,752 (2) (2,337,167 ) Other comprehensive loss (763 ) (763 ) Total Stockholders’ Deficit (462,089 ) (136,265 ) - (598,354 ) Total Liabilities and Stockholders’ Deficit $ 17,548 $ - $ - $ 17,548 CHINA VTV LIMITED AND SUBSIDIARY UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE INCOME(LOSS) China VTV Limited, a Nevada Corporation China VTV Limited, a Hong Kong Company For the Twelve For the Twelve Months ended Months ended February 28,2019 February 28,2019 Pro FormaAdjustment Note CombinedPro Forma Revenues $ - $ - - $ - Cost of revenues - - - - Gross profit - - - - Operating expenses Research and development expenses - 861,581 - 861,581 General and administrative expenses 90,587 13,426 - 104,013 Total operating expenses 90,587 875,007 - 965,594 Loss from operations (90,587 ) (875,007 ) - (965,594 ) Loss before provision for income tax (90,587 ) (875,007 ) - (965,594 ) Provision for income tax (benefit) - - - - Net loss (90,587 ) (875,007 ) - (965,594 ) Other Comprehensive Income (Loss): Foreign currency translation adjustment, net of tax - (37 ) (37 ) Comprehensive Loss $ (90,587 ) $ (875,044 ) $ - $ (965,631 ) Net loss per share attributable to common stockholders Basic and diluted $ (0.00 ) $ (0.00 ) Weighted average number of common shares outstanding Basic and diluted 92,950,820 (3) 269,649,590
Unaudited Pro Forma Condensed Combined Balance Sheet. (A) Sources and Uses (in millions) Sources of funds: Express Scripts cash on hand at September 30, 2011 $ 1,000.0 Term Loan Facility 4,000.0 Existing New Express Scripts Notes 4,086.3 Additional debt financing 4,429.6 Total sources of funds $ 13,515.9 Use of funds: Cash payments to Medco stockholders $ 11,158.9 Payment of Medco 2012 term loan and revolving credit facility due 2013 2,000.0 Express Scripts transaction costs(1) 209.7 New debt issuance costs(2) 147.3 Total use of funds $ 13,515.9
Unaudited Pro Forma Condensed Combined Balance Sheet. As of December 31, 2019 (In thousands) Sonnet BioTherapeutics, Inc. Relief Therapeutics SA Pro Forma Adjustments Notes Pro Forma Sonnet BioTherapeutics, Inc. Reverse Recapitalization Notes Pro Forma Combined Assets Current assets: Cash and cash equivalents $ 889 $ 9 $ 1,355 A $ 2,253 $ 9,000 E $ 11,253 Related party receivable — 1,027 — 1,027 — 1,027 Prepaid expenses and other current assets 20 27 — 47 — 47 Total current assets 909 1,063 1,355 3,327 9,000 12,327 Property and equipment $ 48 $ — — 48 $ — 48 Total assets $ 957 $ 1,063 $ 1,355 $ 3,375 $ 9,000 $ 12,375 Liabilities and stockholders’ equity (deficit) Current liabilities: Related-party notes $ 1 $ — $ — $ 1 $ — $ 1 Accounts payable 3,207 56 (56 ) D 3,207 — 3,207 Other accrued expenses 148 142 — 290 1,042 F 1,332 Total current liabilities 3,356 212 (56 ) 3,512 1,042 4,554 Defined benefit obligation — 138 (138 ) C — — — Total liabilities 3,356 350 (194 ) 3,512 1,042 4,554 Stockholders’ equity (deficit): Common stock 12,510 212 16,980 A,B 29,702 (29,701 ) G 1 Additional paid-in capital — 607 (607 ) B — 42,701 G 42,701 Accumulated deficit (14,909 ) (106 ) (14,824 ) B (29,839 ) (5,042 ) G (34,881 ) Total stockholders’ equity (deficit) (2,399 ) 713 1,549 (137 ) 7,958 7,821 Total liabilities and stockholders’ equity $ 957 $ 1,063 $ 1,355 $ 3,375 $ 9,000 $ 12,375
Unaudited Pro Forma Condensed Combined Balance Sheet. As of September 30, 2022 The following pro forma adjustments give effect to the business combination. Note A Derived from the unaudited condensed consolidated balance sheet of MICT as of September 30, 2022, which are incorporated by reference into this filing. Note B Derived from the unaudited condensed consolidated balance sheet of Tingo as of September 30, 2022, which are incorporated by reference into this filing. Adjustments:
Unaudited Pro Forma Condensed Combined Balance Sheet. March 31, 2022 (Unaudited, expressed in United States dollars) Historical Pro Forma Transaction Accounting Adjustments Augusta Gold. Corp Pro Augusta Gold Corp. CR Reward LLC Acquisition Forma Consolidated Assets Current assets Cash $ 19,024,422 485,521 (17,377,395 ) [5(a)] 2,132,548 Prepaid 134,302 19,521 - 153,823 Deposits 7,028 - - 7,028 Total current assets 19,165,752 505,042 (17,377,395 ) 2,293,399 Other assets Equipment, net 282,501 - - 282,501 Property and plant - 838,991 - [5(b)] 838,991 Mineral properties, net 12,198,388 11,084,945 35,072,722 [5(b)] 58,356,055 Total other assets 12,480,889 11,923,936 35,072,722 59,477,547 Total assets $ 31,646,641 12,428,978 17,695,327 61,770,946 Liabilities and Stockholders’ Equity Current liabilities Accounts payable $ 461,408 63,285 (55,997 ) [5(c)] 468,696 Acquisition obligation - 17,500,000 [5(d)] 17,500,000 Asset retirement obligation 1,039,786 - - 1,039,786 Total current liabilities 1,501,194 63,285 17,444,003 19,008,482 Long term liabilities Asset retirement obligation, net of current 921,441 1,100,434 - [5(e)] 2,021,875 Warrant liability 7,966,950 - - 7,966,950 Total long-term liabilities 8,888,391 1,100,434 - 9,988,825 Total liabilities 10,389,585 1,163,719 17,444,003 28,997,307 Stockholders’ equity Preferred stock, $0.0001 par value - - - - Preferred stock series A, $.0001 par value - - - - Preferred stock series B, $.0001 par value 67 - - 67 Common stock, $.0001 par value 7,052 - 780 [5(f)] 7,832 Member’s capital - 21,317,522 (21,317,522 ) [5(g)] - Additional paid in capital 42,844,691 - 11,515,803 [5(f)] 54,360,494 Accumulated deficit (21,594,754 (10,052,263 ) 10,052,263 [5(g)] (21,594,754 ) Total stockholders’ equity 21,257,056 11,265,259 251,324 32,773,639 Total liabilities and stockholders’ equity $ 31,646,641 12,428,978 17,695,327 61,770,946 See accompanying notes to unaudited pro forma condensed combined financial statements AUGUSTA GOLD CORP.
Unaudited Pro Forma Condensed Combined Balance Sheet. As of September 30, 2023 Note A Derived from the historical condensed consolidated balance sheet of VBL as of September 30, 2023. Note B Derived from the historical condensed balance sheet of Notable as of September 30, 2023. Note C Transaction Accounting Adjustments:
Unaudited Pro Forma Condensed Combined Balance Sheet. The following adjustments have been made to the accompanying Unaudited Pro Forma Condensed Combined Balance Sheet as of September 30, 2021 to reflect the allocation of the fair value of the assets acquired and liabilities assumed for the Pioneer Acquisition and the related financing:
